Viridian Therapeutics Inc
VRDN31.880USD
-0.400-1.24%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
2.62BMarket Cap
LossP/E TTM
Viridian Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
302.00K
-3.82%
EPS(YoY)
-3.98
25.14%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its total revenue reached 302.00K, with a year-on-year change of -3.82%.
What is the Earnings Per Share (EPS) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -3.977, with a year-on-year change of 25.14%.
What is the net income of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its net income was -269.95M, with a year-on-year change of -13.55%.
What is the net margin of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its net profit margin was -89387.09%, with a year-on-year change of -18.06%.
What is the gross margin of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 2.77%, with a year-on-year change of -32.71%.
What is the Return on Equity (ROE) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -75.17%, with a year-on-year change of 22.78%.
What is the Return on Assets (ROA) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -43.79%, with a year-on-year change of 14.75%.
What is the operating profit of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its operating profit was -299.04M, with a year-on-year change of -17.52%.
What are the current assets of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its current assets were 738.46M, with a year-on-year change of 51.80%.
What are the total assets of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its total assets of Viridian Therapeutics Inc were 742.40M, with a year-on-year change of 51.38%.
What are the total liabilities of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its total liabilities of Viridian Therapeutics Inc were 70.76M, with a year-on-year change of 46.20%.
What is the total equity of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its total equity of Viridian Therapeutics Inc was 671.64M, with a year-on-year change of 51.95%.
What is the net operating income of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its net operating income of Viridian Therapeutics Inc was -269.95M, with a year-on-year change of -13.55%.
What is the net investment of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its net investment of Viridian Therapeutics Inc was -228.65M, with a year-on-year change of -142.60%.
What is the net financing of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2024 earnings report, its net financing of Viridian Therapeutics Inc was 457.74M, with a year-on-year change of 102.83%.
